Liraglutide + PYY3-36 combination therapy mimics effects of Roux-en-Y bypass on early NAFLD whilst lacking-behind in metabolic improvements.

Accession: GSE192425
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: drug/treatment response)
Modality / assay: drug-response
Platform: Expression profiling by high throughput sequencing, GPL20084
Organism: Rattus norvegicus
Samples: 69
Size (indexed): 3.9 MB (4061892 bytes)
Downloaded bytes: 3.9 MB (4061892 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE192425_Raw_count_table.csv.gz3.9 MB325b7f42f02cda61…

Index note: 1 file(s); GSE192425_Raw_count_table.csv.gz

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T16:55:35Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL20084 dataset provides single-cell gene expression from rattus norvegicus liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 69 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.